Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls

NCT ID: NCT03176745

Last Updated: 2017-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

153 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-07-01

Study Completion Date

2017-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators aim to determine the optimal number of measurements required for multiple-breath-washout derived lung function parameters in adults with pulmonary disease as well as in healthy controls

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Controls Chronic Obstructive Pulmonary Disease Bronchial Asthma Sarcoidosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

healthy controls

* no history of pulmonary disease
* absence of symptoms, smoking history \< 10 pack years
* normal lung function testing

multiple breath washout

Intervention Type DIAGNOSTIC_TEST

determination of lung clearance index using SF6 multiple breath washout

chronic obstructive pulmonary disease

* clinical history and/or specialist diagnosis of COPD and risk factor(s)
* persistent bronchial obstruction and/or hyperinflation and/or radiological sign of emphysema, each without alternative explanation
* dyspnea, cough and/or sputum production

multiple breath washout

Intervention Type DIAGNOSTIC_TEST

determination of lung clearance index using SF6 multiple breath washout

bronchial asthma

* clinical history and/or specialist diagnosis of bronchial asthma
* respiratory symptoms compatible with asthma varying over time
* variable and/or reversible obstructive ventilation disorder and/or airway hyperresponsiveness
* exclusion of alternative explanation

multiple breath washout

Intervention Type DIAGNOSTIC_TEST

determination of lung clearance index using SF6 multiple breath washout

sarcoidosis

* clinical history and/or specialist diagnosis of sarcoidosis
* lymphocytic alveolitis and CD4/CD8 \> 3.5 in bronchoalveolar lavage and/or noncaseating epithelioid granuloma
* exclusion of alternative explanation

multiple breath washout

Intervention Type DIAGNOSTIC_TEST

determination of lung clearance index using SF6 multiple breath washout

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

multiple breath washout

determination of lung clearance index using SF6 multiple breath washout

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- informed consent

Exclusion Criteria

* inability to perform multiple breath washout testing
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitätsmedizin Mannheim

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Frederik Trinkmann

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Trinkmann F, Gotzmann J, Saur D, Schroeter M, Roth K, Stach K, Borggrefe M, Saur J, Akin I, Michels JD. Multiple breath washout testing in adults with pulmonary disease and healthy controls - can fewer measurements eventually be more? BMC Pulm Med. 2017 Dec 11;17(1):185. doi: 10.1186/s12890-017-0543-y.

Reference Type DERIVED
PMID: 29228942 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MBW-number

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.